Literature DB >> 28510482

Rod Outer Segment Development Influences AAV-Mediated Photoreceptor Transduction After Subretinal Injection.

Lolita Petit1, Shan Ma1, Shun-Yun Cheng1, Guangping Gao2, Claudio Punzo1,3.   

Abstract

Vectors based on the adeno-associated virus (AAV) are currently the preferred tools for delivering genes to photoreceptors (PR) in small and large animals. AAVs have been applied successfully in various models of PR dystrophies. However, unknown barriers still limit AAV's efficient application in several forms of severe PR degenerations due to insufficient transgene expression and/or treated cells at the time of injection. Optimizations of PR gene therapy strategies will likely benefit from the identification of the cellular factors that influence PR transduction. Interestingly, recent studies have shown that the AAV transduction profile of PRs differs significantly between neonatal and adult mouse retinas after subretinal injection. This phenomenon may provide clues to identify host factors that influence the efficiency of AAV-mediated PR transduction. This study demonstrates that rod outer segments are critical modulators of efficient AAV-mediated rod transduction. During retinal development, rod transduction correlated temporally and spatially with the differentiation order of PRs when vectors were introduced subretinally but not when introduced intravitreally. All subretinally injected vectors had an initial preference to transduce cones in the absence of formed rod outer segments and then displayed a preference for rods as the cells matured, independently of the expression cassette or AAV serotype. Consistent with this observation, altered development of rod outer segments was associated with a strong reduction of rod transduction and an increase in the percentage of transduced cones by 2- to 2.8-fold. A similar increase of cone transduction was observed in the adult retinal degeneration 1 (rd1) retina compared to wild-type mice. These results suggest that the loss of rod outer segments in diseased retinas could markedly affect gene transfer efficiency of AAV vectors by limiting the ability of AAVs to infect dying rods efficiently. This information could be exploited for the development of more efficient AAV-based PR gene delivery procedures.

Entities:  

Keywords:  AAV; cones; gene therapy; photoreceptors; retina; rods

Mesh:

Substances:

Year:  2017        PMID: 28510482      PMCID: PMC5488363          DOI: 10.1089/hum.2017.020

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  90 in total

1.  Comparison of photoreceptor-specific matrix domains in the cat and monkey retinas.

Authors:  R N Fariss; D H Anderson; S K Fisher
Journal:  Exp Eye Res       Date:  1990-10       Impact factor: 3.467

2.  Retinal organization in the retinal degeneration 10 (rd10) mutant mouse: a morphological and ERG study.

Authors:  Claudia Gargini; Eva Terzibasi; Francesca Mazzoni; Enrica Strettoi
Journal:  J Comp Neurol       Date:  2007-01-10       Impact factor: 3.215

3.  Long-term retinal function and structure rescue using capsid mutant AAV8 vector in the rd10 mouse, a model of recessive retinitis pigmentosa.

Authors:  Ji-jing Pang; Xufeng Dai; Shannon E Boye; Ilaria Barone; Sanford L Boye; Song Mao; Drew Everhart; Astra Dinculescu; Li Liu; Yumiko Umino; Bo Lei; Bo Chang; Robert Barlow; Enrica Strettoi; William W Hauswirth
Journal:  Mol Ther       Date:  2010-12-07       Impact factor: 11.454

4.  Investigation of the migration path for new rod photoreceptors in the adult cichlid fish retina.

Authors:  Andreas F Mack; Dorina Papanikolaou; Concepción Lillo
Journal:  Exp Neurol       Date:  2003-11       Impact factor: 5.330

5.  Targeting gene expression to cones with human cone opsin promoters in recombinant AAV.

Authors:  A M Komáromy; J J Alexander; A E Cooper; V A Chiodo; L G Glushakova; G M Acland; W W Hauswirth; G D Aguirre
Journal:  Gene Ther       Date:  2008-03-13       Impact factor: 5.250

6.  Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trial.

Authors:  Nicola G Ghazi; Emad B Abboud; Sawsan R Nowilaty; Hisham Alkuraya; Abdulrahman Alhommadi; Huimin Cai; Rui Hou; Wen-Tao Deng; Sanford L Boye; Abdulrahman Almaghamsi; Fahad Al Saikhan; Hassan Al-Dhibi; David Birch; Christopher Chung; Dilek Colak; Matthew M LaVail; Douglas Vollrath; Kirsten Erger; Wenqiu Wang; Thomas Conlon; Kang Zhang; William Hauswirth; Fowzan S Alkuraya
Journal:  Hum Genet       Date:  2016-01-29       Impact factor: 4.132

7.  Novel adeno-associated virus serotypes efficiently transduce murine photoreceptors.

Authors:  Mariacarmela Allocca; Claudio Mussolino; Maria Garcia-Hoyos; Daniela Sanges; Carolina Iodice; Marco Petrillo; Luk H Vandenberghe; James M Wilson; Valeria Marigo; Enrico M Surace; Alberto Auricchio
Journal:  J Virol       Date:  2007-08-15       Impact factor: 5.103

8.  Visual Acuity after Retinal Gene Therapy for Choroideremia.

Authors:  Thomas L Edwards; Jasleen K Jolly; Markus Groppe; Alun R Barnard; Charles L Cottriall; Tanya Tolmachova; Graeme C Black; Andrew R Webster; Andrew J Lotery; Graham E Holder; Kanmin Xue; Susan M Downes; Matthew P Simunovic; Miguel C Seabra; Robert E MacLaren
Journal:  N Engl J Med       Date:  2016-04-27       Impact factor: 91.245

9.  Gene Therapy Fully Restores Vision to the All-Cone Nrl(-/-) Gucy2e(-/-) Mouse Model of Leber Congenital Amaurosis-1.

Authors:  Sanford L Boye; James J Peterson; Shreyasi Choudhury; Seok Hong Min; Qing Ruan; K Tyler McCullough; Zhonghong Zhang; Elena V Olshevskaya; Igor V Peshenko; William W Hauswirth; Xi-Qin Ding; Alexander M Dizhoor; Shannon E Boye
Journal:  Hum Gene Ther       Date:  2015-08-06       Impact factor: 4.793

10.  Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial.

Authors:  Robert E MacLaren; Markus Groppe; Alun R Barnard; Charles L Cottriall; Tanya Tolmachova; Len Seymour; K Reed Clark; Matthew J During; Frans P M Cremers; Graeme C M Black; Andrew J Lotery; Susan M Downes; Andrew R Webster; Miguel C Seabra
Journal:  Lancet       Date:  2014-01-16       Impact factor: 79.321

View more
  10 in total

1.  Therapeutic Benefits from Nanoparticles: The Potential Significance of Nanoscience in Retinal Degenerative Diseases.

Authors:  Raju V S Rajala
Journal:  J Mol Biol Ther       Date:  2019

2.  Aerobic Glycolysis Is Essential for Normal Rod Function and Controls Secondary Cone Death in Retinitis Pigmentosa.

Authors:  Lolita Petit; Shan Ma; Joris Cipi; Shun-Yun Cheng; Marina Zieger; Nissim Hay; Claudio Punzo
Journal:  Cell Rep       Date:  2018-05-29       Impact factor: 9.423

3.  Human iPSC-Derived Retinas Recapitulate the Fetal CRB1 CRB2 Complex Formation and Demonstrate that Photoreceptors and Müller Glia Are Targets of AAV5.

Authors:  Peter M Quinn; Thilo M Buck; Aat A Mulder; Charlotte Ohonin; C Henrique Alves; Rogier M Vos; Monika Bialecka; Tessa van Herwaarden; Elon H C van Dijk; Mays Talib; Christian Freund; Harald M M Mikkers; Rob C Hoeben; Marie-José Goumans; Camiel J F Boon; Abraham J Koster; Susana M Chuva de Sousa Lopes; Carolina R Jost; Jan Wijnholds
Journal:  Stem Cell Reports       Date:  2019-04-04       Impact factor: 7.765

4.  AAV-Mediated Gene Delivery to 3D Retinal Organoids Derived from Human Induced Pluripotent Stem Cells.

Authors:  Marcela Garita-Hernandez; Fiona Routet; Laure Guibbal; Hanen Khabou; Lyes Toualbi; Luisa Riancho; Sacha Reichman; Jens Duebel; Jose-Alain Sahel; Olivier Goureau; Deniz Dalkara
Journal:  Int J Mol Sci       Date:  2020-02-03       Impact factor: 5.923

Review 5.  Viral-Vector-Delivered Anti-Angiogenic Therapies to the Eye.

Authors:  Sanna Koponen; Emmi Kokki; Kati Kinnunen; Seppo Ylä-Herttuala
Journal:  Pharmaceutics       Date:  2021-02-05       Impact factor: 6.321

6.  Adeno-associated virus-mediated neuroglobin overexpression ameliorates the N-methyl-N-nitrosourea-induced retinal impairments: a novel therapeutic strategy against photoreceptor degeneration.

Authors:  Ye Tao; Zhen Yang; Wei Fang; Zhao Ma; Yi Fei Huang; Zhengwei Li
Journal:  Ther Clin Risk Manag       Date:  2017-10-13       Impact factor: 2.423

Review 7.  Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays.

Authors:  Thilo M Buck; Jan Wijnholds
Journal:  Int J Mol Sci       Date:  2020-06-12       Impact factor: 5.923

8.  Gene Therapy Preserves Retinal Structure and Function in a Mouse Model of NMNAT1-Associated Retinal Degeneration.

Authors:  Scott H Greenwald; Emily E Brown; Michael J Scandura; Erin Hennessey; Raymond Farmer; Basil S Pawlyk; Ru Xiao; Luk H Vandenberghe; Eric A Pierce
Journal:  Mol Ther Methods Clin Dev       Date:  2020-07-09       Impact factor: 6.698

9.  Subretinal delivery of erythropoietin alleviates the N-methyl-N-nitrosourea-induced photoreceptor degeneration and visual functional impairments: an in vivo and ex vivo study.

Authors:  Ye Tao; Yue Wang; Zhao Ma; Liqiang Wang; Limin Qin; Lu Wang; Yi Fei Huang; Shizhong Zhang
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

10.  Low-Dose Recombinant Adeno-Associated Virus-Mediated Inhibition of Vascular Endothelial Growth Factor Can Treat Neovascular Pathologies Without Inducing Retinal Vasculitis.

Authors:  Shun-Yun Cheng; Yongwen Luo; Anneliese Malachi; Jihye Ko; Qin Su; Jun Xie; Bo Tian; Haijiang Lin; Xiao Ke; Qiang Zheng; Phillip W L Tai; Guangping Gao; Claudio Punzo
Journal:  Hum Gene Ther       Date:  2021-07       Impact factor: 5.695

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.